Search

everythinglearnresearchcommunity

for

Search:↓

A new skin disease in four Labrador retrievers responded well to immunosuppressive treatment.

Mutations in claudin-1 and claudin-3 cause hair loss in baby mice.

ILC1-like cells may contribute to hair loss in alopecia areata and could be new treatment targets.

Folliculitis decalvans and tufted folliculitis are related, and a new treatment with rifampicin and clindamycin is effective.

Melanocyte-associated antigens may play a key role in alopecia areata and could be targets for new treatments.

The conclusion is that Treg-targeted therapies have potential, but more knowledge of Treg biology is needed for effective treatments, including for cancer.

CD34+ hair follicle stem cells can become melanin-producing cells for treating skin conditions.

The study identified key immune cell differences between mild and severe alopecia areata.

The CLASI is a reliable tool for measuring the severity of cutaneous lupus erythematosus.

Claudin-1 is crucial for maintaining skin barrier and preventing inflammation.

Special immune cells called Treg cells are important for maintaining and regenerating hair by activating a specific growth signal in hair stem cells.

Researchers found a safe and effective way to pick genetically modified skin cells with high growth potential using CD24.

Red light at 627 nm can safely trigger IL-4 release in skin cells, potentially helping treat inflammatory skin conditions.

Mice with human fetal thymic tissue and stem cells developed symptoms similar to chronic graft-versus-host disease.

Researchers found four distinct fibroblast types in human skin, which could help in treating wounds and fibrotic diseases.

A mycobacterial protein shares a similar region with a human skin protein, possibly affecting skin diseases.

Touch dome keratinocytes in adult skin have traits of different skin cell types.

CAR-T cell therapy shows promise for treating autoimmune disorders but faces challenges like complex manufacturing and limited tissue penetration.

γδTregs may help treat autoimmune diseases like alopecia areata by promoting hair regrowth and reducing immune attacks.

Hair follicle development and microbes help regulatory T cells gather in newborn skin.

Scalp involvement in primary cutaneous lymphomas is common and can be aggressive, requiring careful attention.

IL-15 is key for T cell function and could help improve treatments for immune-related diseases.

CCCA may be caused by both hair traction and an immune response.

Dalpiciclib is the safest and most satisfying CDK4/6 inhibitor for advanced breast cancer patients in China.

Alopecia areata patients have higher levels of certain immune receptors, suggesting new treatment possibilities.

Mast cell and nerve fiber interactions in mouse skin change with the hair cycle.

A woman with alopecia regrew her hair after taking a higher dose of tocilizumab.

Canine hair follicle cells show stem cell properties, aiding hair growth.

γδ T cells can prevent and treat alopecia areata, offering a new therapy option.